Tel Aviv, Israel

Anat Globerson Levin

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.5

ph-index = 1


Location History:

  • Tel Aviv, IL (2024)
  • Rehovot, IL (2024)

Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anat Globerson Levin: Innovator in Chimeric Antigen Receptor T-Cell Therapy

Introduction

Anat Globerson Levin is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of cancer treatment through his innovative work on chimeric antigen receptor (CAR) T-cells. With a total of 3 patents, his research focuses on enhancing the efficacy of T-cell therapies for various types of cancer.

Latest Patents

One of his latest patents involves T-cells comprising two different chimeric antigen receptors and their uses. This invention provides T-cells modified to express at least two CARs, with one CAR binding specifically to an antigen selected from CD138, HER2, and CD24, while another CAR binds to a different antigen from the same group. The invention also includes pharmaceutical compositions comprising these CAR T-cells and their application in treating cancer, particularly ovarian cancer.

Another significant patent by Levin features T-cells expressing anti-CD38 and anti-CD138 chimeric antigen receptors. This invention details T-cells that express two different CARs, where one CAR comprises anti-CD138 sc Fv and the second CAR also comprises anti-CD138 sc Fv. The patent further provides a pharmaceutical composition comprising these dual CAR T-cells and their use in treating multiple myeloma, along with methods for preparing these cells.

Career Highlights

Anat Globerson Levin has worked with notable organizations such as Yeda Research and Development Company and the Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center. His work in these institutions has allowed him to advance his research and contribute to the development of innovative cancer therapies.

Collaborations

Levin has collaborated with esteemed colleagues in his field, including Zelig Eshhar and Tova Waks. Their combined expertise has furthered the research and application of CAR T-cell therapies.

Conclusion

Anat Globerson Levin's contributions to the field of cancer treatment through his innovative patents on CAR T-cells highlight his role as a leading inventor in this critical area of medical research. His work continues to pave the way for advancements in cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…